Genome-wide association studies burst onto the scene in the mid-2000s, and they are showing their worth for predicting disease risk, classifying disease, and examining gene-drug interactions, writes Muin Khoury, the director of the public health genomics office at the US Centers for Disease Control and Prevention, at the Genomics and Health Impact Blog.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.